Type I Product Recall of Propofol Injection, 1 g/100 mL and 500 mg/50 mL Due to the Presence of Particulate Matter - Hospira Healthcare Corporation - For Health Professionals
Critical priority
Where it was sold
ON, QCReported in the official notice — confirm there.
Issued by
Health Canada — Marketed health products
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.